Preparation of study documentation (medical writing: protocol, Investigator’s brochure, informed consent form (CRF), diaries, etc.)
Identifying and evaluating study locations (feasibility studies)
Pre-study selection visits
Investigator and site selection
Budget and contract negotiation
Investigator meeting coordination
Regulatory submissions in compliance with international (ICH-GCP) and local requirements
Site setup and staff training
Study materiel management
Management of study medication supply (including QP batch release) and other logistic issues
Monitoring and Handling of study payments
Site management and outsourced site monitoring
Clinical research organization (CRO) oversight
Translation and localization of clinical trial and medical documents
Conducting clinical studies in Israel with Dor Pharmaceutical Services offers significant advantages
National medical insurance coverage – financial barriers to treatment absent
Single-tier medical service – equal treatment across population
47 teaching hospitals feature high-caliber, modern facilities with technology and treatments at western standards
Excellent traceability through computerized medical records
Highly educated, enthusiastic physicians for strong recruitment rates and very low patient lost-to-follow-up rates
Excellent English proficiency among medical staff for effective communication
Experienced, professional study monitors
High data quality recognized by FDA and EMEA
National guidelines for conducting clinical studies compliant with ICH-GCP and EN-540
Efficient ethical approval process
Compact geography for cost-effective monitoring
Population genetically diverse – Israeli clinical results applicable to most developed countries
Key opinion leaders and local societies/working groups in most medical disciplines
Israel ranked 5th per capita for clinical studies
